Well it looks like your more worried about offsetting your capital loss rather than people with bv ( which I did refer to in my post.) The cancer side of things is another issue altogether. Companies have been seeking the “ holy grail” cancer cure for years and even if SPLs technology is as good as led to believe, in reality this is some years off yet, at best. Finally, if spl were to employ another 50 staff for 5 million a year extra in wages, do you think this would speed up the launch process for everyone’s benefit? I don’t. It will happen this year so let’s just leave it at that. Gltah
SPL Price at posting:
$1.17 Sentiment: Buy Disclosure: Held
